Morphic Therapeutic Announces $80 Million Financing to Advance Next-Generation Oral Integrin Therapeutics Through Clinical Proof of Concept

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2DyL88W
via IFTTT